Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

126 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Atezolizumab and bevacizumab in patients with advanced hepatocellular carcinoma with impaired liver function and prior systemic therapy: a real-world experience.
de Castro T, Jochheim LS, Bathon M, Welland S, Scheiner B, Shmanko K, Roessler D, Ben Khaled N, Jeschke M, Ludwig JM, Marquardt JU, Weinmann A, Pinter M, Lange CM, Vogel A, Saborowski A. de Castro T, et al. Among authors: ludwig jm. Ther Adv Med Oncol. 2022 Feb 26;14:17588359221080298. doi: 10.1177/17588359221080298. eCollection 2022. Ther Adv Med Oncol. 2022. PMID: 35251317 Free PMC article.
LiMAx Prior to Radioembolization for Hepatocellular Carcinoma as an Additional Tool for Patient Selection in Patients with Liver Cirrhosis.
Leyh C, Heucke N, Schotten C, Büchter M, Bechmann LP, Wichert M, Dechêne A, Herrmann K, Heider D, Sydor S, Lemmer P, Ludwig JM, Pospiech J, Theysohn J, Damm R, March C, Powerski M, Pech M, Özcürümez M, Weigt J, Keitel V, Lange CM, Schmidt H, Canbay A, Best J, Gerken G, Manka PP. Leyh C, et al. Among authors: ludwig jm. Cancers (Basel). 2022 Sep 21;14(19):4584. doi: 10.3390/cancers14194584. Cancers (Basel). 2022. PMID: 36230506 Free PMC article.
Prediction of left lobe hypertrophy after right lobe radioembolization of the liver using a clinical data model with external validation.
Theysohn JM, Demircioglu A, Kleditzsch M, Ludwig JM, Weber M, Umutlu L, Li Y, Kircher M, Lapa C, Buck A, Koehler M, Wildgruber M, Lange CM, Palard X, Garin E, Herrmann K, Forsting M, Nensa F. Theysohn JM, et al. Among authors: ludwig jm. Sci Rep. 2022 Dec 1;12(1):20718. doi: 10.1038/s41598-022-25077-6. Sci Rep. 2022. PMID: 36456637 Free PMC article.
Bilobar Radioembolization Carries the Risk of Radioembolization-Induced Liver Disease in the Treatment of Advanced Hepatocellular Carcinoma: Safety and Efficacy Comparison to Systemic Therapy with Atezolizumab/Bevacizumab.
Jeschke M, Ludwig JM, Leyh C, Pabst KM, Weber M, Theysohn JM, Lange CM, Herrmann K, Schmidt HH, Jochheim LS. Jeschke M, et al. Among authors: ludwig jm. Cancers (Basel). 2023 Aug 26;15(17):4274. doi: 10.3390/cancers15174274. Cancers (Basel). 2023. PMID: 37686549 Free PMC article.
126 results